NCT00125372: Study of Tarceva and Targretin in Stage I-II Lung Cancer |
|
|
| Completed | N/A | 12 | US | erlotinib (Tarceva) and bexarotene (Targretin), Tarceva, Targretin | Dartmouth-Hitchcock Medical Center, Ligand Pharmaceuticals, Genentech, Inc. | Carcinoma, Non-small-cell Lung | 08/10 | 08/10 | | |
NCT02551718: High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia |
|
|
| Completed | N/A | 34 | US | Chemosensitivity Assay, Chemosensitivity Testing, Cytology Specimen Collection Procedure, Cytologic Sampling, Gene Expression Analysis, Genetic Variation Analysis, Genetic Variation, GENVAR, mutation analysis, In Vitro Sensitivity-Directed Chemotherapy | University of Washington, National Cancer Institute (NCI) | Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Refractory Acute Leukemia of Ambiguous Lineage | 06/20 | 05/21 | | |
